⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Valsartan

والسارتان

⚠ Unverified

❤️ Cardiovascular SystemAngiotensin receptor blocker (ARB)

🤰 Pregnancy:Dangerous / avoid 🤱 Breastfeeding:Dangerous / avoid 👶 Children:Use with caution 👴 Older adults:No specific problem stated 🇮🇷 Registered in Iran ⛔ 2 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA204011 ATC C09CA03

Market / country: 🇺🇸 USA

Diovan (US)

🧮 Dose calculator

Disease / regimen

Hypertension · Regimen source: FDA Valsartan · 2.2

• Range 80–320 mg once daily. FDA Valsartan · 2.2

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ Not recommended under 1 year. FDA Valsartan · 8.4
⚠️ Boxed warning: fetal toxicity — stop as soon as pregnancy is detected. FDA Valsartan · Boxed Warning

Renal adjustment

• eGFR < 30: No data in children with GFR <30 or on dialysis. FDA Valsartan · 8.4

Formulations

40 mg tablet (scored) — tablet 🇺🇸 USA FDA Valsartan · 3
80 mg tablet — tablet 🇺🇸 USA FDA Valsartan · 3
160 mg tablet — tablet 🇺🇸 USA FDA Valsartan · 3
320 mg tablet — tablet 🇺🇸 USA FDA Valsartan · 3

👥 Special populations

🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Valsartan · Boxed Warning
“( 5.1 ) WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.”
🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Valsartan · 8.2
“Because of the potential for serious adverse reactions in breastfed infants from exposure to valsartan, advise a nursing woman that breastfeeding is not recommended during treatment with valsartan.”
👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Valsartan · 8.4
“Use of valsartan is not recommended in children less than 1 year of age.”
👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Valsartan · 8.5
“Exposure [measured by area under the curve (AUC)] to valsartan is higher by 70% in the elderly than in the young, however no dosage adjustment is necessary [see Clinical Pharmacology (12.3) ] .”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)ANDA204011
DailyMed (FDA label)FDA Valsartan
MedlinePlus (NIH)Valsartan
WHO ATC/DDDC09CA03
Darooyab (Iran)Valsartan

🇮🇷 Registered in Iran Darooyab · G-1929/Valsartan

Dosage forms with Iranian generic codes, per Darooyab.

05561 · VALSARTAN 160MG CAP · کپسول والسارتان ۱۶۰ میلی‌گرم
05766 · VALSARTAN 160MG TAB · قرص والسارتان ۱۶۰ میلی‌گرم
07095 · VALSARTAN 40MG CAP · کپسول والسارتان ۴۰ میلی‌گرم
09801 · VALSARTAN 40MG TAB · قرص والسارتان ۴۰ میلی‌گرم
05560 · VALSARTAN 80MG CAP · کپسول والسارتان ۸۰ میلی‌گرم
05423 · VALSARTAN 80MG TAB · قرص والسارتان ۸۰ میلی‌گرم

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Valsartan · 3 FDA Valsartan · 2.2 FDA Valsartan · 2, Table FDA Valsartan · 2.3 FDA Valsartan · 2.1 FDA Valsartan · 2.4 FDA Valsartan · 8.4 FDA Valsartan · Boxed Warning FDA Valsartan · 8.2 FDA Valsartan · 8.5 FDA Valsartan · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-1929/Valsartan
Clinical review⚠ Unverified